Results for: drugmaker+novartis+ag

Drug maker Novartis loses India patent battle

Analysis: Bribery scandal dents Big Pharma sales in China, GSK hardest hit

Swiss voters approve tough limits on bosses' pay

Valeant raises cash-stock offer for Allergan

Pfizer pulls plug on push to buy AstraZeneca

Indian court to rule on generic drug industry

Swiss vote on bosses' pay could hit offshore firms

Drugmakers, Interpol ramp up fight against fakes

Analysis - Bribery scandal dents Big Pharma sales in China, GSK hardest hit

Novartis and Google to develop 'smart' contact lens

Novartis Q4 net profit rebounds to $2.1 billion

India's rejection of drug patent could reverberate

Exclusive - Sanofi explores $7 billion-plus sale of drug portfolio: sources

Merck Q4 net drops 14 pct. on generic competition

India's Sun Pharma plans gradual phase-out of Ranbaxy-branded drugs in...

Drugmaker Novartis to eke out more cost savings to lift margins

India's top court to deliver Novartis judgment

Novartis loses new bid to dismiss U.S. lawsuit over kickbacks

Swiss mull creation of world's top minimum wage

Pfizer 1Q profit up, but drugmaker cuts outlook

Novartis, Pfizer seek US approval of meningitis vaccines

Big Pharma pushes for U.S. action against India over patent worries

Novartis lung cancer drug gets key FDA designation

Investor pressure pushing drugmaker M&A deals

Tokyo prosecutors raid Novartis Japan unit over clinical data probe

US emergency labs ready to work on Ebola drugs if asked

India rejects Bayer plea against cheap cancer drug

Ahead of the Bell: Biogen shares keep climbing

Novartis reshapes business with GSK, Lilly deals